Probiotic-associated Bacillus subtilis subsp. subtilis catheter-related bloodstream infection in a preterm infant: a

Jiajia Chen1, Xuelan Liu2, Xiang Huang2

  • 1Department of Clinical Pharmacy, Jieyang People's Hospital, Jieyang, Guangdong, China.

Insights

A preterm infant developed catheter-related bloodstream infection (CRBSI) during Bacillus subtilis probiotic therapy. This case highlights the potential infectious risks of probiotics in neonates with central venous catheters.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Probiotics are increasingly used in neonatal care.
  • Bacillus subtilis is a commonly used probiotic strain.
  • Catheter-related bloodstream infections (CRBSI) are a significant concern in neonates.

Purpose of the Study:

  • To report a case of CRBSI potentially linked to Bacillus subtilis probiotic administration.
  • To raise awareness of potential infectious risks associated with probiotics in vulnerable neonates.

Main Methods:

  • Case report of a preterm infant receiving oral Bacillus subtilis probiotic.
  • Diagnosis of CRBSI confirmed by differential time to positivity in blood cultures.
  • Antimicrobial susceptibility profiling of clinical isolates and the probiotic strain.

Main Results:

  • The preterm infant developed systemic inflammation during probiotic therapy.
  • CRBSI was diagnosed.
  • Clinical isolates and the probiotic strain exhibited identical antimicrobial susceptibility profiles, suggesting a potential link.

Conclusions:

  • Bacillus subtilis probiotic administration may pose an infectious risk in neonates, especially those with central venous access.
  • Probiotics should be considered a potential source of sepsis in neonates with CRBSI.
  • Further investigation into the safety of probiotics in neonatal populations is warranted.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...